US 12152244
Selective antisense compounds and uses thereof
granted A61PA61P25/14A61P25/28
Quick answer
US patent 12152244 (Selective antisense compounds and uses thereof) held by Ionis Pharmaceuticals, Inc. expires Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Nov 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61P, A61P25/14, A61P25/28